Virtual event Oct. 29: Arntzen Grand Challenges Lecture

Virtual event Oct. 29: Arntzen Grand Challenges Lecture

October 29, 2020

Location

Zoom | RSVP here

Date and Time

October 29, 2020, 6:00 pm (Length: 1 hour 0 minutes)

iCal Download

Pandemic smarts: Taking aim against the stealthy coronavirus

What do we really know about the coronavirus? And how can we fight it? The coronavirus pandemic has upended society and dramatically changed the face of scientific research. The unprecedented global shift towards the singular goal of understanding how this novel coronavirus works and how to stop it has contributed to a remarkably rapid and deep understanding of the viral lifecycle. 

What: The Biodesign Institute will host a virtual lecture on the coronavirus.

Who: UC Berkley's Britt Glaunsinger will share what we know about how this pandemic virus invades and replicates in our cells and emerging strategies to stop it. She is an expert on how viruses interface with and hijack cellular pathways that control gene expression. Glaunsinger will describe the latest findings and will highlight the viral components that are targets for therapeutic interventions and vaccine design, whose degrees of success may ultimately define the duration of this pandemic. 

Glaunsinger is the UC Berkeley Class of 1963 endowed chair and professor in the Departments of Plant and Microbial Biology and Molecular and Cellular Biology at the University of California Berkeley, and an investigator of the Howard Hughes Medical Institute.

When: Oct. 29, 6-7 p.m.

Where: Virtual lecture. 

Cost: The event is free and open to all. 

Sign up here by Oct. 23, to join a live online talk followed by a question and answer session with this virus expert.

The event is part of the Arntzen Grand Challenges Lecture series.

The Arntzen Grand Challenges Lecture series is inspired by Charles Arntzen, founding director of the ASU Biodesign Institute. Arntzen is internationally recognized for his novel applied research on the development of genetic strategies for using plants to manufacture pharmaceuticals and produce cost-effective vaccines or drugs to save lives around the world, especially in developing nations.

The Biodesign Institute delivers the future of nature-inspired scientific innovation today for the betterment of human health, community safety and global sustainability.